Randomized Phase II Trial of Sunitinib and Docetaxel in Advanced Gastric Cancer Patients Who Had Prior Chemotherapy With Fluoropyrimidine and Platinum.
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2012
At a glance
- Drugs Docetaxel (Primary) ; Sunitinib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2012 Planned End Date changed from 1 Dec 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 11 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.